Vertex Pharmaceuticals Incorporated
STEM CELL DERIVED ISLET DIFFERENTIATION
Last updated:
Abstract:
Provided herein are methods of producing .beta. cells and precursors thereof utilizing a Wnt signaling inhibitor or PKC activator, or both. Also provided herein are in vitro cultures comprising said cells, methods of treating a subject with a disease characterized by high blood sugar levels over a prolonged period of time by administering said cells, and devices for encapsulating said cells.
Status:
Application
Type:
Utility
Filling date:
9 Feb 2021
Issue date:
5 Aug 2021